Related Experiment Video
Updated: Jul 1, 2025

Assessment of Mitochondrial Health in Cancer-Associated Fibroblasts Isolated from 3D Multicellular Lung Tumor Spheroids
Published on: October 21, 2022
Aberrantly downregulated FENDRR by arecoline elevates ROS and myofibroblast activation via mitigating the
Yi-Wen Liao1, Cheng-Chia Yu2, Chang-Wei Hsieh3
1Department of Medical Research, Chung Shan Medical University Hospital, Taichung 402, Taiwan; Institute of Oral Sciences, Chung Shan Medical University, Taichung 402, Taiwan.
Abstract:
Long non-coding RNA FENDRR possesses both anti-fibrotic and anti-cancer properties, but its significance in the development of premalignant oral submucous fibrosis (OSF) remains unclear. Here, we showed that FENDRR was downregulated in OSF specimens and fibrotic buccal mucosal fibroblasts (fBMFs), and overexpression of FENDRR mitigated various myofibroblasts hallmarks, and vice versa. In the course of investigating the mechanism underlying the implication of FENDRR in myofibroblast transdifferentiation, we found that FENDRR can directly bind to miR-214 and exhibit its suppressive effect on myofibroblast activation via titrating miR-214. Moreover, we showed that mitofusin 2 (MFN2), a protein that is crucial to the fusion of mitochondria, was a direct target of miR-214. Our data suggested that FENDRR was positively correlated with MFN2 and MFN2 was required for the inhibitory property of FENDRR pertaining to myofibroblast phenotypes. Additionally, our results showed that the FENDRR/miR-214 axis participated in the arecoline-induced reactive oxygen species (ROS) accumulation and myofibroblast transdifferentiation. Building on these results, we concluded that the aberrant downregulation of FENDRR in OSF may be associated with chronic exposure to arecoline, leading to upregulation of ROS and myofibroblast activation via the miR-214-mediated suppression of MFN2.
Insights
Long non-coding RNA FENDRR, crucial in oral submucous fibrosis (OSF), suppresses myofibroblast activation by regulating miR-214 and mitofusin 2. Its downregulation links to arecoline exposure, promoting OSF progression.
Area of Science:
- Molecular Biology
- Oncology
- Fibrosis Research
Background:
- Long non-coding RNA FENDRR exhibits anti-fibrotic and anti-cancer roles.
- Its function in premalignant oral submucous fibrosis (OSF) is not well understood.
Purpose of the Study:
- To investigate the role of FENDRR in oral submucous fibrosis (OSF) development.
- To elucidate the molecular mechanism of FENDRR in myofibroblast transdifferentiation.
Main Methods:
- Analysis of FENDRR expression in OSF tissues and cells.
- Overexpression and knockdown studies of FENDRR.
- RNA-binding assays to confirm FENDRR-miR-214 interaction.
- Western blotting for MFN2 expression.
- Assessment of reactive oxygen species (ROS) levels.
Main Results:
- FENDRR was downregulated in OSF specimens and fibrotic buccal mucosal fibroblasts (fBMFs).
- FENDRR overexpression inhibited myofibroblast hallmarks, while its downregulation promoted them.
- FENDRR directly targets miR-214, suppressing myofibroblast activation.
- Mitofusin 2 (MFN2) is a direct target of miR-214; FENDRR positively correlates with MFN2.
- The FENDRR/miR-214 axis influences arecoline-induced ROS accumulation and myofibroblast transdifferentiation.
Conclusions:
- Aberrant FENDRR downregulation in OSF is linked to chronic arecoline exposure.
- This downregulation promotes ROS and myofibroblast activation via miR-214-mediated MFN2 suppression.
- FENDRR acts as a tumor suppressor in OSF by inhibiting myofibroblast activation.
Related Concept Videos
MAPK Signaling Cascades
Cell-matrix's Response to Mechanical Forces
Anchoring junctions mechanically attach a cell to the...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

